Eureka Therapeutics (United States)
ORCID: 0009-0005-7867-0244Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability”.
Weiqun Liu, Nicole C. Fay, Diane M Da Silva, Li Ou, Chris S. Rae +18 more